SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories informs about outcome of board meeting

18 Jun 2026 Evaluate
Pursuant to the Regulation 30 of the SEBI (LODR), 2015, Coral Laboratories has informed that the board on its meeting held on Thursday, June 18, 2026 considered and approved the proposal for increase in remuneration of Meera Doshi who is holding office/ place of profit; and Postal Ballot Notice to seek shareholders’ approval. The Meeting commenced at 11:45 am and was concluded by 12:30 pm on the same day.

The above information is a part of company’s filings submitted to BSE.

Coral Laboratories Share Price

549.45 49.45 (9.89%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: